Top

Published in:

01-05-2020 | Human Immunodeficiency Virus | Original Paper

Biomedical HIV Protection Among Gay and Bisexual Men Who Use Crystal Methamphetamine

Authors: Mohamed A. Hammoud, Fengyi Jin, Lisa Maher, Adam Bourne, Bridget Haire, Peter Saxton, Stefanie Vaccher, Toby Lea, Louisa Degenhardt, Garrett Prestage

Published in: AIDS and Behavior | Issue 5/2020

Abstract

Use of crystal methamphetamine (crystal) among gay and bisexual men (GBM) has been associated with condomless anal intercourse with casual partners (CLAIC) and HIV infection. Pre-exposure prophylaxis (PrEP) and undetectable viral load (UVL) are important biomedical HIV prevention strategies. We investigate the relationship between crystal use and HIV sexual risk behaviours in the context of PrEP and UVL. In 2018, 1367 GBM provided details about crystal use and HIV prevention strategies. Binary logistic regression was used to estimate associations between crystal use and behaviour. Recent crystal use was independently associated with greater social engagement with gay men and having more sexual partners. Crystal use was also independently associated with use of PrEP and UVL among GBM who engaged in CLAIC. Although GBM who used crystal were more likely to have engaged in CLAIC, they were also more likely to use biomedical HIV prevention which mitigates against the risks of HIV infection.

Jin F, Crawford J, Prestage GP, et al. Unprotected anal intercourse, risk reduction behaviours, and subsequent HIV infection in a cohort of homosexual men. AIDS. 2009;23(2):243–52. https://doi.org/10.1097/QAD.0b013e32831fb51a.CrossRefPubMedPubMedCentral

Piyaraj P, van Griensven F, Holtz TH, et al. The finding of casual sex partners on the internet, methamphetamine use for sexual pleasure, and incidence of HIV infection among men who have sex with men in Bangkok, Thailand: an observational cohort study. Lancet HIV. 2018;5(7):e379–89.PubMedPubMedCentral

Plankey MW, Ostrow DG, Stall R, et al. The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study. JAIDS. 2007;45(1):85.PubMed

Prestage G, Jin F, Kippax S, et al. Use of illicit drugs and erectile dysfunction medications and subsequent HIV infection among gay men in Sydney, Australia. J Sex Med. 2009;6(8):2311–20. https://doi.org/10.1111/j.1743-6109.2009.01323.x.CrossRefPubMed

Jin F, Jansson J, Law M, et al. Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS. 2010;24(6):907–13. https://doi.org/10.1097/QAD.0b013e3283372d90.CrossRefPubMedPubMedCentral

Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New Engl J Med. 2010;363(27):2587–99. https://doi.org/10.1056/NEJMoa1011205.CrossRefPubMed

McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53–60. https://doi.org/10.1016/s0140-6736(15)00056-2.CrossRefPubMedPubMedCentral

Molina J-M, Capitant C, Spire B, et al. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection. New Eng J Med. 2015;373(23):2237–46. https://doi.org/10.1056/NEJMoa1506273.CrossRefPubMed

Bavinton BR, Pinto AN, Phanuphak N, et al. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV. 2018;5(8):e438–47. https://doi.org/10.1016/s2352-3018(18)30132-2.CrossRefPubMed

10.

Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. New Eng J Med. 2011;365(6):493–505. https://doi.org/10.1056/NEJMoa1105243.CrossRefPubMed

11.

Rodger A, Cambiano V, Bruun T, et al. Risk of HIV transmission through condomless sex in MSM couples with suppressive ART: The PARTNER2 Study extended results in gay men. Paper presented at: Journal of the International AIDS Society 2018.

12.

Rodger AJ, Cambiano V, Bruun T, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA. 2016;316(2):171–81. https://doi.org/10.1001/jama.2016.5148.CrossRefPubMed

13.

Roxburgh A, Lea T, de Wit J, Degenhardt L. Sexual identity and prevalence of alcohol and other drug use among Australians in the general population. Int J Drug Policy. 2016;28:76–82. https://doi.org/10.1016/j.drugpo.2015.11.005.CrossRefPubMed

14.

Broady T, Mao L, Bavinton B, et al. Gay Community Periodic Survey: Adelaide 2018. Sydney: Centre for Social Research in Health, UNSW Australia. 2019. http://unsworks.unsw.edu.au/fapi/datastream/unsworks:58353/binbe9ddc0f-f25b-43fa-a05c-3e07887bf418?view=true. Accessed 19 April 2019.

15.

Lee E, Mao L, Broady T, et al. Gay Community Periodic Survey: Melbourne 2018. Sydney: Centre for Social Research in Health, UNSW Australia. 2018. http://unsworks.unsw.edu.au/fapi/datastream/unsworks:50970/bin35d6913b-dbd9-48d5-bf80-a0ace96e3dc4?view=true&xy=01. Accessed 19 April 2019.

16.

Broady T, Lee E, Mao L, et al. Gay Community Periodic Survey: Queensland 2018. Sydney: Centre for Social Research in Health, UNSW Australia. 2019. http://unsworks.unsw.edu.au/fapi/datastream/unsworks:57313/bin9693fa2d-d2ae-4831-b00d-b102885f0e84?view=true. Accessed 19 April 2019.

17.

Broady T, Mao L, Lee E, et al. Gay Community Periodic Survey: Sydney 2018. Sydney: Centre for Social Research in Health, UNSW Australia. 2018. http://unsworks.unsw.edu.au/fapi/datastream/unsworks:52117/binae80f831-8458-4fec-8c2b-1f7ba7402409?view=true. Accessed 19 April 2019.

18.

Broady T, Mao L, Lee E, et al. Gay Community Periodic Survey: Tasmania 2018. Sydney: Centre for Social Research in Health, UNSW Australia. 2019. http://unsworks.unsw.edu.au/fapi/datastream/unsworks:55228/bin2d640fa7-71b3-4372-bb3b-1fd49f94494f?view=true. Accessed 19 April 2019.

19.

Halkitis PN, Fischgrund BN, Parsons JT. Explanations for methamphetamine use among gay and bisexual men in New York City. Subst Use Misuse. 2005;40(9–10):1331–45.PubMed

20.

Semple SJ, Patterson TL, Grant I. Motivations associated with methamphetamine use among HIV men who have sex with men. J Subst Abuse Treat. 2002;22(3):149–56.PubMed

21.

Weatherburn P, Hickson F, Reid D, Torres-Rueda S, Bourne A. Motivations and values associated with combining sex and illicit drugs (‘chemsex’) among gay men in South London: findings from a qualitative study. Sex Transm Infect. 2017;93(3):203–6.PubMed

22.

Bourne A, Reid D, Hickson F, Torres-Rueda S, Weatherburn P. Illicit drug use in sexual settings (‘chemsex’) and HIV/STI transmission risk behaviour among gay men in South London: findings from a qualitative study. Sex Transm Infect. 2015;91(8):564–8.PubMed

23.

Stuart D. Chemsex: origins of the word, a history of the phenomenon and a respect to the culture. Drugs Alcohol Today. 2019;19(1):3–10. https://doi.org/10.1108/DAT-10-2018-0058.CrossRef

24.

Lea T, Mao L, Hopwood M, et al. Methamphetamine use among gay and bisexual men in Australia: trends in recent and regular use from the Gay Community Periodic Surveys. Int J Drug Policy. 2016;29:66–72.PubMed

25.

Prestage G, Fogarty AS, Rawstorne P, et al. Use of illicit drugs among gay men living with HIV in Sydney. AIDS. 2007;21:49–55.

26.

Saxton P, Newcombe D, Ahmed A, Dickson N, Hughes A. Illicit drug use among New Zealand gay and bisexual men: prevalence and association with sexual health behaviours. Drug Alcohol Rev. 2018;37(2):180–7.PubMed

27.

Vosburgh HW, Mansergh G, Sullivan PS, Purcell DW. A review of the literature on event-level substance use and sexual risk behavior among men who have sex with men. AIDS Behav. 2012;16(6):1394–410.PubMed

28.

Hammoud MA, Vaccher S, Jin F, et al. HIV pre-exposure prophylaxis (PrEP) uptake among gay and bisexual men in australia and factors associated with the nonuse of PrEP among eligible men: results from a prospective cohort Study. JAIDS. 2019;81(3):e73–84.PubMed

29.

Holt M. Gay Men’s HIV risk reduction practices: the influence of epistemic communities in hiv social and behavioral research. AIDS Educ Prev. 2014;26(3):214–23. https://doi.org/10.1521/aeap.2014.26.3.214.CrossRefPubMed

30.

Kippax S, Crawford J, Davis M, Rodden P, Dowsett G. Sustaining safe sex: a longitudinal study of a sample of homosexual men. AIDS. 1993;7(2):257–63.PubMed

31.

Bryant J, Rance J, Treloar C. Annual Report of Trends in Behaviour 2019: Viral Hepatitis in Australia. Sydney: Centre for Social Research in Health, UNSW Sydney. 2019. http://unsworks.unsw.edu.au/fapi/datastream/unsworks:59969/binc1fe6e52-2310-4461-b820-a36c94de5d4f?view=true&xy=01. Accessed 7 June 2019.

32.

Southgate E, Hopwood M. The role of folk pharmacology and lay experts in harm reduction: sydney gay drug using networks. Int J Drug Policy. 2001;12(4):321–35.

33.

NPS MedicineWise. PrEP on the PBS: an opportunity in HIV prevention. 2018. https://www.nps.org.au/news/pr-ep-on-the-pbs-an-opportunity-in-hiv-prevention. Accessed 7 June 2019.

34.

Wright E, Grulich A, Roy K, et al. Australasian Society for HIV, viral hepatitis and sexual health medicine HIV pre-exposure prophylaxis: clinical guidelines. J Virus Erad. 2017;3(3):168–84.PubMedPubMedCentral

35.

Wright E, Grulich A, Roy K, et al. Australasian society for HIV, viral hepatitis and sexual health medicine HIV pre-exposure prophylaxis: clinical guidelines. J Virus Erad. 2018;4(2):143.PubMedPubMedCentral

36.

Holt M, Lea T, Mao L, et al. Community-level changes in condom use and uptake of HIV pre-exposure prophylaxis by gay and bisexual men in Melbourne and Sydney, Australia: results of repeated behavioural surveillance in 2013–17. Lancet HIV. 2018;5(8):e448–56.PubMed

37.

Keen P, Gray RT, Telfer B, et al. The 2016 HIV diagnosis and care cascade in New South Wales, Australia: meeting the UNAIDS 90-90-90 targets. J Int AIDS Soc. 2018;21(4):e25109. https://doi.org/10.1002/jia2.25109.CrossRefPubMedPubMedCentral

38.

Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2018. Sydney: Kirby Institute, UNSW Sydney 2018. https://kirby.unsw.edu.au/sites/default/files/kirby/report/KI_Annual-Surveillance-Report-2018.pdf. Accessed 28 June 2019.

39.

Hammoud MA, Vaccher S, Jin F, et al. The new MTV generation: using methamphetamine, Truvada™, and Viagra™ to enhance sex and stay safe. Int J Drug Policy. 2018;55:197–204.PubMed

40.

Jin F, Prestage GP, Mao L, et al. “Any condomless anal intercourse” is no longer an accurate measure of HIV sexual risk behavior in gay and other men who have sex with men. Front Immunol. 2015;6:86.PubMedPubMedCentral

41.

Hammoud MA, Jin F, Degenhardt L, et al. Following Lives Undergoing Change (Flux) study: implementation and baseline prevalence of drug use in an online cohort study of gay and bisexual men in Australia. Int J Drug Policy. 2017;41:41–50. https://doi.org/10.1016/j.drugpo.2016.11.012.CrossRefPubMed

42.

Halkitis PN, Parsons JT. Recreational drug use and HIV-risk sexual behavior among men frequenting gay social venues. J Gay Lesbian Soc Serv. 2002;14(4):19–38.

43.

Bavinton BR, Duncan D, Grierson J, et al. The meaning of ‘regular partner’in HIV research among gay and bisexual men: implications of an Australian cross-sectional survey. AIDS Behav. 2016;20(8):1777–84.PubMed

44.

Kippax S, Campbell D, Van de Ven P, et al. Cultures of sexual adventurism as markers of HIV seroconversion: a case control study in a cohort of Sydney gay men. AIDS Care. 1998;10(6):677–88.PubMed

45.

Löwe B, Decker O, Müller S, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008;46(3):266–74.PubMed

46.

Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.PubMed

47.

Chagas MHN, Tumas V, Rodrigues GR, et al. Validation and internal consistency of Patient Health Questionnaire-9 for major depression in Parkinson’s disease. Age Ageing. 2013;42(5):645–9.PubMed

48.

Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Inter Med. 2001;16(9):606–13.

49.

Rosenberg M. Society and the adolescent self-image. Princeton: Princeton University Press; 2015.

50.

Robins RW, Hendin HM, Trzesniewski KH. Measuring global self-esteem: construct validation of a single-item measure and the Rosenberg Self-Esteem Scale. Pers Soc Psychol Bull. 2001;27(2):151–61.

51.

Gaither GA, Sellbom M. The sexual sensation seeking scale: reliablity and validity within a heterosexual college student sample. J Pers Assess. 2003;81(2):157–67.PubMed

52.

Kalichman SC, Rompa D. Sexual sensation seeking and sexual compulsivity scales: validity, and predicting HIV risk behavior. J Pers Assess. 1995;65(3):586–601.PubMed

53.

Vaccher SJ, Gianacas C, Templeton DJ, et al. Baseline preferences for daily, event-driven, or periodic HIV pre-exposure prophylaxis among gay and bisexual men in the PRELUDE demonstration project. Front Public Health. 2017;5:341.PubMedPubMedCentral

54.

Cochran SD, Ackerman D, Mays VM, Ross MW. Prevalence of non-medical drug use and dependence among homosexually active men and women in the US population. Addiction. 2004;99(8):989–98. https://doi.org/10.1111/j.1360-0443.2004.00759.x.CrossRefPubMedPubMedCentral

55.

Roux P, Fressard L, Suzan-Monti M, et al. Is on-demand HIV pre-exposure prophylaxis a suitable tool for men who have sex with men who practice chemsex? Results from a substudy of the ANRS-IPERGAY trial. JAIDS. 2018;79(2):e69–75.PubMed

56.

Prestage G, Maher L, Grulich A, et al. Brief report: changes in behavior after PrEP initiation among Australian Gay and Bisexual Men. JAIDS. 2019;81(1):52–6.PubMed

57.

Kirby Institute. National HIV Quarterly Report: Q4 2018. National HIV Quarterly Report: Q4 2018. 2019. https://kirby.unsw.edu.au/sites/default/files/kirby/report/National-HIV-Quarterly-Report_2018-Q4.pdf. Accessed 8 July 2019.

58.

Murphy D. Off-label: the changing boundaries of prevention. HIV Aust. 2015;13(2):25.

59.

Kippax S, Race K. Sustaining safe practice: twenty years on. Soc Sci Med. 2003;57(1):1–12. https://doi.org/10.1016/s0277-9536(02)00303-9.CrossRefPubMed

60.

Zablotska IB, Holt M, Prestage G. Changes in gay men’s participation in gay community life: implications for HIV surveillance and research. AIDS Behav. 2012;16(3):669–75.PubMed

61.

Isaiah Green A, Halkitis PN. Crystal methamphetamine and sexual sociality in an urban gay subculture: an elective affinity. Cult Health Sex. 2006;8(4):317–33.

62.

Prestage G, Hammoud M, Jin F, et al. Mental health, drug use and sexual risk behavior among gay and bisexual men. Int J Drug Policy. 2018;55:169–79.PubMed

63.

Mao L, Kidd MR, Rogers G, et al. Social factors associated with Major Depressive Disorder in homosexually active, gay men attending general practices in urban Australia. Aust NZ J Public Health. 2009;33(1):83–6. https://doi.org/10.1111/j.1753-6405.2009.00344.x.CrossRef

64.

McLaren S, Jude B, McLachlan AJ. Sense of belonging to the general and Gay communities as predictors of depression among Australian Gay Men. Int J Men’s Health. 2008;7(1):90–9.

65.

Prestage GP, Hudson J, Jin F, et al. Testing for HIV and sexually transmissible infections within a mainly online sample of gay men who engage in group sex. Sex Transm Infect. 2009;85(1):70–4.PubMed

66.

Grulich AE, Guy R, Amin J, et al. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Lancet HIV. 2018;5(11):e629–37.PubMed

67.

Holt M, Lea T, Mao L, et al. Adapting behavioural surveillance to antiretroviral-based HIV prevention: reviewing and anticipating trends in the Australian Gay Community Periodic Surveys. Sex Health. 2017;14(1):72–9. https://doi.org/10.1071/sh16072.CrossRefPubMed

68.

Girometti N, Gutierrez A, Nwokolo N, McOwan A, Whitlock G. High HIV incidence in men who have sex with men following an early syphilis diagnosis: is there room for pre-exposure prophylaxis as a prevention strategy? Sex Transm Infect. 2017;93(5):320–2.PubMed

69.

Sewell J, Miltz A, Lampe FC, et al. Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics. Int J Drug Policy. 2017;43:33–43.PubMed

Title: Biomedical HIV Protection Among Gay and Bisexual Men Who Use Crystal Methamphetamine
Authors: Mohamed A. Hammoud
Fengyi Jin
Lisa Maher
Adam Bourne
Bridget Haire
Peter Saxton
Stefanie Vaccher
Toby Lea
Louisa Degenhardt
Garrett Prestage
Publication date: 01-05-2020
Publisher: Springer US
Keyword: Human Immunodeficiency Virus
Published in: AIDS and Behavior / Issue 5/2020
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-019-02739-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2020

Efficacy is Not Everything: Eliciting Women’s Preferences for a Vaginal HIV Prevention Product Using a Discrete-Choice Experiment

The PrEP Care Continuum Among Cisgender Women Who Sell Sex and/or Use Drugs Globally: A Systematic Review

Social Determinants of Potential eHealth Engagement Among People Living with HIV Receiving Ryan White Case Management: Health Equity Implications from Project TECH

Intimate Partner Violence and Pre-exposure Prophylaxis (PrEP): A Rapid Review of Current Evidence for Women’s HIV Prevention

Effectiveness of an Intervention for Improving Treatment Adherence, Service Utilization and Viral Load Among HIV-Positive Adult Alcohol Users

Associations Between Relationship Power and Pre-Exposure Prophylaxis (PrEP) Use Among Men Who Have Sex With Men

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage